The Cooper Companies, Inc. (COO)
BMV
Real-time Data
02:30 PM
Day's Range
1,243.0052 wk Range
1,051.99Overview - COO - The Cooper Companies, Inc.
Key Statistics
Valuation
Enterprise Value
4.14T
P/E (Trailing)
‪62.11‬
PEG Ratio
‪-0.32‬
Price / Sales (TTM)
‪57.29‬
Price / Book
‪1.72‬
EV / EBITDA
‪276.41‬
Profitability
Gross Margin
‪67.99%‬
Profit Margin
‪5.57%‬
Operating Margin
‪-2.86%‬
Return on Assets
‪2.51%‬
Return on Equity
‪2.85%‬
Ownership
Shares Outstanding
194.91M
Float
193.67M
Held by Insiders
‪0.61%‬
Held by Institutions
‪109.22%‬
Price stats
Beta
‪0.82‬
50-Day Avg
‪1,209.05‬
200-Day Avg
‪1,287.73‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Semi-Annual
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - COO - The Cooper Companies, Inc.
Peers - COO - The Cooper Companies, Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on BMV.
Profile Summary - COO - The Cooper Companies, Inc.
About
The Cooper Companies, Inc. is a global medical device company focused on eyecare and women’s health, headquartered in San Ramon, California. The business operates through two main segments: CooperVision and CooperSurgical. CooperVision develops, manufactures, and markets a broad portfolio of contact lenses, including…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
